TNGXTango Therapeutics, Inc.
$23.34+155% 1Y
$23.34
$7.4952 weeks$32.90
Is the price fair?
What TNGX's price assumes
Tango Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 65.9× revenue.
65.9
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.84
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 60.2
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.84
- EV / EBIToperating margin −228%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 60.2
- Market capitalisation168.6 million shares, counted Aug 4, 2026
- $3.94B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks